Thanks, tigr, liked what I heard. Hope it also reassures longs here that Scott is very professional, and will do massive research before he publishes an article. This will bring much needed attention to IBIO.Promises to be a very interesting day on Monday. Thanks also to Justin, his research and postings about it are very informative. GLTA
Mo, Im cautiously excited about this week but remember the real payday is if PLX gets approval for tac alpha. This will open the door for all plant based biologics and will be a screaming buy for all small cap funds/hedge funds to buy IBIO. Good luck and by the way his name is Julian and the press he could give us is MUCH LARGER than a seeking alpha article, Julian is in contact with the "Wall Street Journal" and could have a big article there anyday now, now that the H1N1 phase 1 data came out perfectly. "WSJ" now that would get the word out!